Immix Biopharma, Inc.IMMXNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+41.6%
5Y CAGR+116.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+41.6%/yr
Annual compound
5Y CAGR
+116.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
48x
Strong expansion
Streak
4 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.91M | +5.4% |
| 2024 | $11.29M | +29.3% |
| 2023 | $8.74M | +108.2% |
| 2022 | $4.20M | +3216.1% |
| 2021 | $126527.00 | -49.0% |
| 2020 | $248149.00 | -57.4% |
| 2019 | $583162.00 | - |